Jaguar Health (JAGX) Net Cash Flow Growth (5y) (2019 - 2026)
Jaguar Health (JAGX) Net Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.99% |
| Dec 31, 2025 | -8.54% |
| Sep 30, 2025 | 24.09% |
| Jun 30, 2025 | -35.14% |
| Mar 31, 2025 | -0.59% |
| Dec 31, 2024 | -37.27% |
| Sep 30, 2024 | -52.19% |
| Jun 30, 2024 | 45.84% |
| Mar 31, 2024 | 319.89% |
| Dec 31, 2023 | 11.67% |
| Sep 30, 2023 | -26.13% |
| Jun 30, 2023 | -1.10% |
| Mar 31, 2023 | 4.70% |
| Dec 31, 2022 | -184.35% |
| Sep 30, 2022 | 21.20% |
| Jun 30, 2022 | -46.00% |
| Mar 31, 2022 | 12.36% |
| Dec 31, 2021 | 49.31% |
| Sep 30, 2021 | -56.79% |
| Jun 30, 2021 | 36.98% |